|
|
Mechanistic Study on the Regulation of Diabetes Kidney Disease by METTL3 through the miR-126-Mediated TGF-β/Smad Signaling Pathway |
ZHANG Jing, REN Rong, Patiguli·ASITANBAI |
The Fifth Affiliated Hospital of Xinjiang Medical University, Xinjiang Urumqi 830011, China |
|
|
Abstract Objective: To establish a rat model of diabetic kidney disease (DKD) and explore the mechanism by which METTL3 regulates DKD.Methods: After 7 days of adaptive feeding, SD rats were randomly divided into four groups: normal control group (Control group), DKD model group (DKD group), DKD model + METTL3 interference control group (DKD+NC group), and DKD model + METTL3 interference group (DKD+siMETTL3 group), with 8 rats in each group. After modeling, blood specimens and kidney tissues were collected, and levels of fasting blood glucose (FBG), blood urea nitrogen (BUN), 24-hour urine protein (UTP), gene expression of miR-126 using RT-qPCR, expression of TGF-β1 using ELISA, and protein levels of METTL3, smad2, smad3, and smad7 using Western blotting were analyzed by a fully automatic biochemical analyzer. Results: Compared to the control group, the DKD group showed significant increases in FBG, BUN, UTP, TGF-β1, METTL3, smad2, and smad3 (P<0.05), and significant decreases in body weight, miR-126, and smad7 (P<0.05). When compared to the DKD group, the DKD+siMETTL3 group exhibited significant decreases in FBG, BUN, UTP, TGF-β1, METTL3, smad2, and smad3 (P<0.05), and significant increases in body weight, miR-126, and smad7 (P<0.05). Conclusion: METTL3 can mediate the progression of DKD by regulating miR-126 and TGF-β/smad pathway.
|
|
|
|
|
[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂,2021,13(4):315-409. [2] Tuttle KR,Agarwal R,Alpers CE,et al.Molecular mechanisms and therapeutic targets for diabetic kidney disease[J].Kidney Int,2022,102(2):248-260. [3] 汪霞,张娜.m6A甲基化:糖尿病及其并发症的关键驱动因素[J].河北医科大学学报,2022,43(10):1215-1219. [4] 吴佳晋,钟晨,李大伟,等.甲基转移酶3调控pri-miR-21甲基化修饰在糖尿病肾病肾脏纤维化中的作用[J].上海交通大学学报(医学版),2023,43(1):1-7. [5] Yu J,Shen L,Liu Y,et al.The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling[J].Mol Cell Biochem,2020,463(1-2):203-210. [6] 张静,张洁,莫颖,等.METTL3/miR-126调控TGF-β1/smad2对高糖诱导的肾小管上皮细胞增殖的影响[J].广西医科大学学报,2022,39(3):456-461. [7] Jiang L,Liu X,Hu X,et al.METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy[J].Mol Ther,2022,30(3):1721-1740. [8] Sun W,Li Y,Ma D,et al.ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1[J].Cell Mol Biol Lett,2022,27(1):26. [9] 袁瑾,赵灿,张渭涛.依普利酮通过靶向微小 RNA192和微小 RNA-29a/b/c减轻糖尿病肾病模型大鼠肾损伤机制研究[J].陕西医学杂志,2022,51(3):293-297,302. [10] 胡滨滨,张明.非编码RNA的m6A修饰及其在肿瘤中的研究进展[J].中国癌症防治杂志,2021,13(4):430-435. [11] 李昌金,郭志福,黄松群.m6A甲基化调节非编码RNA在心血管疾病中的作用[J].生命的化学,2022,42(7):1248-1254 [12] 潘保朝,李函舟,张辉,等.中医药调控TGF-β1/Smad信号通路治疗糖尿病肾病的研究进展[J].中国实验方剂学杂志,2022,28(23):237-249. |
|
|
|